Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Payables: 2019-2024

Historic Payables for Revolution Medicines (RVMD) over the last 6 years, with Dec 2024 value amounting to $54.4 million.

  • Revolution Medicines' Payables rose 206.06% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.5 million, marking a year-over-year increase of 57.86%. This contributed to the annual value of $54.4 million for FY2024, which is 11.91% down from last year.
  • As of FY2024, Revolution Medicines' Payables stood at $54.4 million, which was down 11.91% from $61.8 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Payables ranged from a high of $61.8 million in FY2023 and a low of $12.6 million during FY2020.
  • In the last 3 years, Revolution Medicines' Payables had a median value of $54.4 million in 2024 and averaged $45.8 million.
  • In the last 5 years, Revolution Medicines' Payables spiked by 190.00% in 2023 and then dropped by 11.91% in 2024.
  • Revolution Medicines' Payables (Yearly) stood at $12.6 million in 2020, then climbed by 11.48% to $14.1 million in 2021, then skyrocketed by 51.57% to $21.3 million in 2022, then surged by 190.00% to $61.8 million in 2023, then decreased by 11.91% to $54.4 million in 2024.